TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Repolar Pharmaceuticals Oy
Closing information (x1000 SEK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
9,146
|
7,792
|
8,830 |
| Financial expenses |
9
|
0 | |
| Earnings before taxes |
842
|
9
|
0 |
| Total assets |
5,807
|
4,796
|
4,853 |
| Current assets |
1,225
|
767
|
4,472 |
| Current liabilities |
976
|
813
|
714 |
| Equity capital |
4,841
|
3,983
|
4,139 |
| - share capital |
507
|
484
|
504 |
| Employees (average) |
6
|
4
|
5 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
83.4%
|
83.0%
|
85.3% |
| Turnover per employee |
1,524
|
1,948
|
1,766 |
| Profit as a percentage of turnover |
9.2%
|
0.1%
|
0% |
| Return on assets (ROA) |
0.4%
|
0% | |
| Current ratio |
125.5%
|
94.3%
|
626.3% |
| Return on equity (ROE) |
17.4%
|
0.2%
|
0% |
| Change turnover |
985
|
-685 | |
| Change turnover % |
12%
|
-8% | |
| Chg. No. of employees |
2
|
-1 | |
| Chg. No. of employees % |
50%
|
-20% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.